Skip to main content

Table 3 Cox regression analysis for the prediction of biochemical recurrence in all patients from two academic centres

From: Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate

 

All patients (n = 293, 69 BCR)

Hazard ratio (95% CI)

P

Intraductal carcinoma of prostate

2.39 (1.44–3.97)

0.001

Adjuvant radiation therapy

0.38 (0.17–0.85)

0.018

Grade group

1.28 (1.00–1.62)

0.046

Extraprostatic extension

1.84 (1.07–3.15)

0.027

Positive margins

2.12 (1.28–3.50)

0.003

Seminal vesicle invasion

1.35 (0.67–2.69)

0.400

  1. IDC-P Intraductal carcinoma of the prostate, CI Confidence interval